These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26818647)

  • 1. Understanding the new pregnancy and lactation drug labeling.
    Watkins EJ; Archambault M
    JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
    Fantasia HC; Harris AL
    Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
    Ramoz LL; Patel-Shori NM
    Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
    Tassinari MS; Sahin L; Yao LP
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication use in pregnancy and the pregnancy and lactation labeling rule.
    Sahin L; Nallani SC; Tassinari MS
    Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
    Beroukhim K; Abrouk M; Farahnik B
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes coming to pregnancy labeling.
    Traynor K
    Am J Health Syst Pharm; 2015 Feb; 72(3):175-6. PubMed ID: 25596595
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Brucker MC; King TL
    J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
    Greene MF
    Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use.
    Feibus KB
    J Med Toxicol; 2008 Dec; 4(4):284-8. PubMed ID: 19031382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
    Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
    J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule.
    Freeman MP; Farchione T; Yao L; Sahin L; Taylor L; Huybrechts KF; Nonacs R; Sosinsky AZ; Viguera AC; Cohen LS
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30153401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice.
    Danesh MJ; Murase JE
    J Am Acad Dermatol; 2015 Aug; 73(2):310-1. PubMed ID: 26183972
    [No Abstract]   [Full Text] [Related]  

  • 15. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information on the risk of drugs in pregnancy: New regulation of the Food and Drug Administration].
    García Caeiro ÁL; Rey Liste MT; Ventosa Rial JJ; Alonso Fachado A
    Aten Primaria; 2017 Dec; 49(10):622-623. PubMed ID: 28844480
    [No Abstract]   [Full Text] [Related]  

  • 17. Availability of Safe and Effective Therapeutic Options to Pregnant and Lactating Individuals Following the United States Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Patel A; Sushko K; Mazer-Amirshahi M; Pfuma Fletcher E; Fusch G; Chan O; Aghayi A; Chan AKC; Lacaze-Masmonteil T; Van Den Anker J; Samiee-Zafarghandy S
    J Pediatr; 2023 Aug; 259():113342. PubMed ID: 36806753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Supervised Learning Methods to Develop a List of Prescription Medications of Greatest Concern during Pregnancy.
    Ailes EC; Zimmerman J; Lind JN; Fan F; Shi K; Reefhuis J; Broussard CS; Frey MT; Cragan JD; Petersen EE; Polen KD; Honein MA; Gilboa SM
    Matern Child Health J; 2020 Jul; 24(7):901-910. PubMed ID: 32372243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special Interest Group-Sponsored Update in Psychosomatics: Food and Drug Administration Revises Pregnancy and Lactation Drug Labeling.
    Dresner N; Sachdeva J
    Psychosomatics; 2016; 57(4):439-40. PubMed ID: 27283251
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations.
    Nallani SC; Baisden K; Dinatale M; Basham L; Kwatra D; Yao L
    J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S159-S169. PubMed ID: 37317496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.